Related Experiment Video

Updated: Jun 1, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Primary excision margins and sentinel lymph node biopsy in clinically node-negative melanoma of the trunk or

J M G Larkin, M E Gore

    Clinical Oncology (Royal College of Radiologists (Great Britain))
    |June 11, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
    09:38

    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

    Published on: January 31, 2025

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
    07:51

    The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

    Published on: June 1, 2019

    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
    09:38

    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

    Published on: January 31, 2025

    Related Concept Videos

    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

    Articles linked to this work by shared authors, journal, and citation graph.

    Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

    Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020

    A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanoma.

    Clinical and experimental dermatology·2015

    Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.

    British journal of cancer·2015

    Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT).

    European journal of cancer (Oxford, England : 1990)·2014

    Increasing the use of Radical Radiotherapy is Associated with Improved Lung Cancer Specific Survival-A Regional Population-based Patient-level Study.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Multidisciplinary Tumor Board in Oropharyngeal Cancer: Impact on Treatment Regimen, Treatment Initiation and Survival.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    HYPOCON: A Randomised Proof of Concept Clinical Trial of Biphasic Fractionation Schedules to Overcome Hypoxia in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Treated with Curative Intent Primary Chemo-radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Acute Myocardial Infarction in Head and Neck Cancer Patients and Survivors: A Population-Based Cohort Study of Patient, Disease, and Treatment Factors.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Patient-reported Outcomes after Standard and Dose-escalated Prostate Stereotactic Body Radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: a Multicenter Prospective Observational Study (COSMOS-MEL01).

    Cancer research communications·2026

    TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR.

    Endocrine-related cancer·2026

    Risk factors for subsequent thyroid neoplasms development in childhood cancer survivors.

    Endocrine-related cancer·2026

    Trends in Location of Death for Individuals with Primary Ocular Cancer in the United States.

    Ophthalmic epidemiology·2026

    Prognostic Value of Intraoperative Desmopressin Test for Long-Term Remission in Cushing's Disease: A Prospective Cohort Study.

    Neurosurgery·2026

    Primary Tumor Histologic Regression and Immunotherapy Outcomes in Recurrent or Metastatic Melanoma.

    Cancer investigation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us